| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 06/14/2011 | US7960143 Method for simultaneous production of multiple proteins; vectors and cells for use therein |
| 06/14/2011 | US7960137 Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter |
| 06/14/2011 | US7960136 Direct antimicrobial susceptibility assay |
| 06/14/2011 | US7960135 Compositions and methods for cell characterization |
| 06/14/2011 | US7960134 Kinase inhibition models and their uses |
| 06/14/2011 | US7960133 Methods of diagnosing leiomyoma by measuring catechol-O-methyltransferase |
| 06/14/2011 | US7960132 Measuring device, measuring apparatus, and measuring method |
| 06/14/2011 | US7960129 Assays and methods for determining STIM2 activity |
| 06/14/2011 | US7960128 TRP8, a transient receptor potential channel expressed in taste receptor cells |
| 06/14/2011 | US7960127 Using channel protein to identify inhibitors of bitter and/or sweet taste preception |
| 06/14/2011 | US7960121 Methods and compositions for diagnosing and monitoring transplant rejection |
| 06/14/2011 | US7960120 Method for pair-wise sequencing a plurality of double stranded target polynucleotides |
| 06/14/2011 | US7960119 Combinatorial decoding of random nucleic acid arrays |
| 06/14/2011 | US7960118 EGFR mutations |
| 06/14/2011 | US7960117 Promoter mutations that increase amyloid precursor protein expression |
| 06/14/2011 | US7960116 Nucleic acid sequencing methods and systems |
| 06/14/2011 | US7960115 DNA binding protein |
| 06/14/2011 | US7960114 Gene signature of early hypoxia to predict patient survival |
| 06/14/2011 | US7960113 DNA analysis method and DNA analyzer |
| 06/14/2011 | US7960112 Gene methylation in cancer diagnosis |
| 06/14/2011 | US7960111 NALP7-based diagnosis of female reproductive conditions |
| 06/14/2011 | US7960110 Detection of chromosomal region copy number changes to diagnose melanoma |
| 06/14/2011 | US7960109 mRNA ratios in urinary sediments and/or urine as a prognostic and/or theranostic marker for prostate cancer |
| 06/14/2011 | US7960108 Using cleavage polymorphism in sterol regulator element binding proteins (SREBP) gene as evaluative tool in predicting/diagnosing clinical outcomes associated with viral infection, nervous system and cholesterol disorders |
| 06/14/2011 | US7960107 Method of determining the susceptibility of a subject to developing insulin-dependent diabetes |
| 06/14/2011 | US7960106 Diagnostic method and products useful therein |
| 06/14/2011 | US7960105 Method of DNA analysis using micro/nanochannel |
| 06/14/2011 | US7960104 Self-assembled single molecule arrays and uses thereof |
| 06/14/2011 | US7960103 Method for obtaining new life forms |
| 06/14/2011 | US7960102 Regulated aptamer therapeutics |
| 06/14/2011 | US7960101 Method for using division arrested cells in screening assays |
| 06/14/2011 | US7960100 Colon cancer targets and uses thereof |
| 06/14/2011 | US7959929 isolated influenza virus that is capable of infecting a canid animal; genetic engineered influenza virus; vaccines for inducing an immune response against an influenza virus; veterinary medicine |
| 06/14/2011 | CA2785999A1 Mean dna copy number of chromosomal regions is of prognostic significance in cancer |
| 06/14/2011 | CA2581226C Thermostable mutants of pyrroloquinoline quinone dependent glucose dehydrogenase |
| 06/14/2011 | CA2578680C Proteolytic markers as diagnostic biomarkers for cancer, organ injury and muscle rehabilitation/exercise overtraining |
| 06/14/2011 | CA2481844C System for tracing animal products |
| 06/14/2011 | CA2478203C Encoded self-assembling chemical libraries (esachel) |
| 06/14/2011 | CA2459354C Amplification and detection reagents for hiv-1 |
| 06/14/2011 | CA2443515C Methods and kits useful for the simplification of complex peptide mixtures |
| 06/14/2011 | CA2426292C Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression |
| 06/14/2011 | CA2404618C Electrically-conductive patterns for monitoring the filling of medical devices |
| 06/14/2011 | CA2399846C Gm-negative ehv-mutants |
| 06/14/2011 | CA2387788C Systems and methods for performing magnetic chromatography assays |
| 06/14/2011 | CA2322700C Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to binds to preselected sites |
| 06/14/2011 | CA2311646C Tsa305 gene |
| 06/14/2011 | CA2182621C Galanin receptor, nucleic acids, transformed cells and uses thereof |
| 06/10/2011 | CA2724942A1 Virally induced biofilm-like structure and uses thereof |
| 06/10/2011 | CA2724132A1 Amplification system with spatial separation |
| 06/10/2011 | CA2688105A1 Virally induced biofilm-like structure and uses thereof |
| 06/09/2011 | WO2011069156A2 Compositions and methods for enhancing odorant receptor activity |
| 06/09/2011 | WO2011069125A1 Bcr-abl1 splice variants and uses thereof |
| 06/09/2011 | WO2011069116A1 Binding ligand linked drug delivery conjugates of tubulysins |
| 06/09/2011 | WO2011069100A2 Microrna and use thereof in identification of b cell malignancies |
| 06/09/2011 | WO2011069058A1 Methods for predecting and treating a sterile inflammation and discriminating between sterile and infective inflammation |
| 06/09/2011 | WO2011069029A2 Lateral flow assays |
| 06/09/2011 | WO2011069004A1 Mpl mutations in jak2 v617f negative patients with myeloproliferative disease |
| 06/09/2011 | WO2011068909A2 Aptamer cell compositions |
| 06/09/2011 | WO2011068865A1 Micro-rna-101 promotes estrogen-independent growth and confers tamoxifen resistance in er-positive cancer cells |
| 06/09/2011 | WO2011068863A1 Combination therapy for treating cancer and diagnostic assays for use therein |
| 06/09/2011 | WO2011068839A1 Classification of cancers |
| 06/09/2011 | WO2011068832A1 Multi drug response markers for breast cancer cells |
| 06/09/2011 | WO2011068829A1 Biomarkers for determining an allograft tolerant phenotype |
| 06/09/2011 | WO2011068798A1 Methods of modulating thrombocytopenia and modified transgenic pigs |
| 06/09/2011 | WO2011068679A1 Methods for the diagnosis of bacterial vaginosis |
| 06/09/2011 | WO2011068654A1 Vitamin d detection by mass spectrometry with laser diode thermal desorption |
| 06/09/2011 | WO2011068610A1 Methods for detecting risk of myelodysplastic syndrome by genotypic analysis |
| 06/09/2011 | WO2011068546A2 Prognosis, diagnosis and identification of multiple myeloma based on global gene expression profiling |
| 06/09/2011 | WO2011068518A1 Multiplexed quantitative pcr end point analysis of nucleic acid targets |
| 06/09/2011 | WO2011068465A1 A method and apparatus for recovering cells and their analysis |
| 06/09/2011 | WO2011068221A1 Method for screening of substance capable of promoting recovery of skin barrier function |
| 06/09/2011 | WO2011068218A1 Kit and method for identification of causative bacterium of nail tinea |
| 06/09/2011 | WO2011068189A1 Method for detecting microorganisms belonging to mycoplasma pneumoniae and/or mycoplasma genitalium |
| 06/09/2011 | WO2011068176A1 Method for detecting cholangiocellular carcinoma and method of screening for prophylactic or therapeutic agent |
| 06/09/2011 | WO2011068166A1 Method of screening for agent for improving dry skin associated with atopic dermatitis employing activity of bleomycin hydrolase activity as measure |
| 06/09/2011 | WO2011068165A1 Identification and inhibition of plant-derived sugar-chain-added enzyme gene |
| 06/09/2011 | WO2011068088A1 GENE EXPRESSION ANALYSIS METHOD USING TWO DIMENSIONAL cDNA LIBRARY |
| 06/09/2011 | WO2011068050A1 Mutant enzyme and application thereof |
| 06/09/2011 | WO2011067970A1 Sweet taste receptor expression construct, cell body expressing same, and uses therefor |
| 06/09/2011 | WO2011067765A1 System and method for analyzing dna mixtures |
| 06/09/2011 | WO2011067725A2 Oligonucleotides and methods for detecting lavender foal syndrome |
| 06/09/2011 | WO2011067678A2 Compositions and methods for performing hybridizations with no denaturation |
| 06/09/2011 | WO2011067630A1 Method and kit for dna extraction from vitis vinifera l. and for amplification and detection of grapevine varieties or cultivars in musts or wines |
| 06/09/2011 | WO2011067559A1 Biochemical analysis instrument |
| 06/09/2011 | WO2011067549A1 Melanoma specific biomarker |
| 06/09/2011 | WO2011067516A1 Method for quick identification of viruses by means of mass spectrometry |
| 06/09/2011 | WO2011067378A1 Method for amplification of target nucleic acid |
| 06/09/2011 | WO2011067373A1 Method for detecting polycythemia in a dog |
| 06/09/2011 | WO2011067346A1 Method for determining the efficiency of a cancer treatment |
| 06/09/2011 | WO2011067299A1 Method for detecting and quantifying poly(a) rna and mrna |
| 06/09/2011 | WO2011067296A1 A combination of eight risk alleles associated with autism |
| 06/09/2011 | WO2011067202A1 Improved method for screening a potential modulator compound of a taste receptor |
| 06/09/2011 | WO2011067133A2 Selective enrichment of non-methylated nucleic acids |
| 06/09/2011 | WO2011066660A1 Lsc and hsc signatures for predicting survival of patients having hematological cancer |
| 06/09/2011 | WO2011066621A1 Diagnostic and therapeutic methods for corneal ectasia following refractive surgery, keratoconus or pellucid degeneration |
| 06/09/2011 | WO2011047019A9 An objective, quantitative method to predict histological subtype in non-small cell lung cancer |
| 06/09/2011 | WO2011046597A8 Biomarkers and identification methods for the early detection and recurrence prediction of breast cancer using nmr |
| 06/09/2011 | WO2011028533A3 Methods for detecting dna methylation using encoded particles |
| 06/09/2011 | WO2011017696A3 Methods relating to aromatase inhibitor pharmacogenetics |
| 06/09/2011 | WO2011008349A3 Methods of identifying infectious disease and assays for identifying infectious disease |